SUDARSHAN PHARMA INDUSTRIES
Back to Balance Sheet
|
SUDARSHAN PHARMA INDUSTRIES Last 5 Year Total Non-Current Liabilities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Total Non-Current Liabilities | ₹11 Cr | ₹11 Cr | ₹13 Cr | ₹5.12 Cr | ₹5.48 Cr |
What is the latest Total Non-Current Liabilities ratio of SUDARSHAN PHARMA INDUSTRIES ?
| Year | Total Non-Current Liabilities |
|---|---|
| Mar2025 | ₹11 Cr |
| Mar2024 | ₹11 Cr |
| Mar2023 | ₹13 Cr |
| Mar2022 | ₹5.12 Cr |
| Mar2021 | ₹5.48 Cr |
How is Total Non-Current Liabilities of SUDARSHAN PHARMA INDUSTRIES Trending?
| Years | Total Non-Current Liabilities | % Change | |
|---|---|---|---|
| Mar2025 | ₹11 Cr | 2.81 | |
| Mar2024 | ₹11 Cr | -16.13 | |
| Mar2023 | ₹13 Cr | 154.35 | |
| Mar2022 | ₹5.12 Cr | -6.58 | |
| Mar2021 | ₹5.48 Cr | - | |
Compare Total Non-Current Liabilities of peers of SUDARSHAN PHARMA INDUSTRIES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| SUDARSHAN PHARMA INDUSTRIES | ₹926.4 Cr | -6% | -9.3% | 25.3% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹422,283.0 Cr | 0.1% | -5% | 5.4% | Stock Analytics | |
| DIVIS LABORATORIES | ₹244,762.0 Cr | -1.7% | 0.2% | 39.5% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹173,448.0 Cr | -2.5% | -5.5% | 30.2% | Stock Analytics | |
| CIPLA | ₹107,043.0 Cr | 0.9% | -2.6% | -14.6% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹102,820.0 Cr | 0.1% | 7.6% | -3.5% | Stock Analytics | |
SUDARSHAN PHARMA INDUSTRIES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| SUDARSHAN PHARMA INDUSTRIES | -6% |
-9.3% |
25.3% |
| SENSEX | 3.1% |
1% |
-9.1% |
You may also like the below Video Courses